Have you ever heard of the drug Daraprim? Probably not. Nonetheless, it’s a drug that’s used by people with HIV to help fight off potentially deadly parasitic infections. The company with the rights to this drug is Turing Pharmaceuticals and it’s run by a man named Martin Shkreli, a former hedge-fund manager who’s bringing a Wall Street attitude to the pharmaceutical industry. After acquiring Daraprim earlier this year, Shkreli decided to raise its price from $13.50 per tablet to $750 per tablet, despite the fact that this is not a new medicine, it isn’t facing massive shortages, and it doesn’t cost anywhere close to $750 per tablet for the company to produce.
Read more here:: Boy Genius Report